Abdulrahman Alshammari

Dr. Abdulrahman Alshammari


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in Journal of Infection and Public Health
Verified
Journal Article
Open access
MSMuhammad Suleman
Muhammad Suleman
ASAbrar Mohammad Sayaf
Abrar Mohammad Sayaf
AKAbbas Khan
Abbas Khan
SKSalman Ali Khan
Salman Ali Khan
NANoorah A. Albekairi
Noorah A. Albekairi
Sergio CrovellaSergio Crovella
Sergio Crovella
Influenza A virus causes severe respiratory illnesses, especially in developing nations where most child deaths under 5 occur due to lower respiratory tract infections. The RIG-I protein acts as a sensor for viral dsRNA, triggering interferon production through K63-linked poly-ubiquitin chains synthesized by TRIM25. However, the influenza A virus's NS1 protein hinders this process by binding to TRIM25, disrupting its association with RIG-I and preventing downstream interferon signalling, contributing to the virus's evasion of the immune response. In our study we used structural-based drug designing, molecular simulation, and binding free energy approaches to identify the potent phytocompounds from various natural product databases (>100,000 compounds) able to inhibit the binding of NS1 with the TRIM25. The molecular screening identified EA-8411902 and EA-19951545 from East African Natural Products Database, NA-390261 and NA-71 from North African Natural Products Database, SA-65230 and SA- 4477104 from South African Natural Compounds Database, NEA- 361 and NEA- 4524784 from North-East African Natural Products Database, TCM-4444713 and TCM-6056 from Traditional Chinese Medicines Database as top hits. The molecular docking and binding free energies results revealed that these compounds have high affinity with the specific active site residues (Leu95, Ser99, and Tyr89) involved in the interaction with TRIM25. Additionally, analysis of structural dynamics, binding free energy, and dissociation constants demonstrates a notably stronger binding affinity of these compounds with the NS1 protein. Moreover, all selected compounds exhibit exceptional ADMET properties, including high water solubility, gastrointestinal absorption, and an absence of hepatotoxicity, while adhering to Lipinski's rule. Our molecular simulation findings highlight that the identified compounds demonstrate high affinity for specific active site residues involved in the NS1-TRIM25 interaction, exhibit exceptional ADMET properties, and adhere to drug-likeness criteria, thus presenting promising candidates for further development as antiviral agents against influenza A virus infections.

26 June 2025 in Journal of Infection and Public Health
Verified
Journal Article
Open access
TATalal Alshammari
Talal Alshammari
AAAbdulrahman Alshammari
Abdulrahman Alshammari
MAMetab Alharbi
Metab Alharbi
Abdullah F. AlAsmariAbdullah F. AlAsmari
Abdullah F. AlAsmari
AAAbdullah Alhamed
Abdullah Alhamed
AAAmal F. Alshammary
Amal F. Alshammary
Antibiotic resistance, mainly caused by methicillin-resistant Staphylococcus aureus (MRSA), is a globally growing concern and a significant health issue in regard to infectious diseases. This issue will require a novel and comprehensive strategy to overcome the resistance to MRSA. Therefore, the current study advances TMPK-targeted drug discovery by screening a vast chemical space using virtual screening with detailed dynamics and binding energy evaluations. In contrast to the previous efforts, our study focuses on the pharmacological exploitation of TMPK's conserved and druggable active site in MRSA, which lacks homologs in humans and remains understated in antimicrobial pipelines. We screened traditional Chinese medicine and African natural compound databases, as well as the InterBioScreen, dark chemical matter, and Maybridge databases, using a three-step virtual screening strategy. From these databases, we identified 16 compounds as the most potent based on their docking and redocking scores and interaction profiles with the key residues. Of these, the top eight hits were re-validated using the induced-fit docking method, which confirmed the validity of these hits' interaction and inhibitory potential against TMPK. Thereafter, using molecular simulations, 500 ns each, we determined that these compounds exhibited stable dynamic profiles, minimal residual fluctuation, and well-folded conformations during the simulation. Furthermore, using the binding free energy calculations, including both the MMGBSA and MMPBSA methods, the top hits were ranked based on the strongest binding energy, which provides compelling evidence for the stability, specificity, and high binding affinity of these compounds towards TMPK. PCA (Principal Component Analysis) and FEL (Free Energy Landscape) analyses revealed the conformational behavior of these complexes. Furthermore, ADMET analysis confirmed the safety of these molecules. This study identified potential therapeutic hits using computational and theoretical approaches; however, experimental validation through in vitro enzymatic assays and MRSA culture-based inhibition studies is essential to confirm their therapeutic potencies.